相关实验视频

Updated: Jun 18, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

用同位素诱导的多能干干细胞建模胆血病

Ana Fragoso Fonseca¹, Rita Coelho¹, Mafalda Lopes- da-Silva¹

¹iNOVA4Health, NOVA Medical School | Faculdade de Ciências Médicas, NMS | FCM, Universidade Nova de Lisboa, Lisboa, Portugal.

Stem cells and development

|July 30, 2024

概括

胆血症 (CHM) 是一种罕见的遗传性眼病. 研究人员使用诱导多能干细胞创建了新的人类细胞模型,以更好地研究CHM及其对视网膜色素表皮细胞的影响.

科学领域:

眼科医生眼科眼科
遗传学遗传学是一个
细胞生物学细胞生物学

背景情况:

胆血症 (CHM) 是一种X关联胆肌变性,由于CHM基因的突变,导致逐渐视力丧失.
这种疾病涉及胆,视网膜色素上皮 (RPE) 和视网膜的退化,而RPE功能障碍起着关键作用.
现有的细胞模型,如ARPE-19,不能完全复制本地RPE细胞特征,限制疾病研究.

研究的目的:

开发基于人类的新型细胞模型,用于研究胆固醇病 (CHM).
为了生成同源的人类诱导多能干细胞 (hiPSC) 线,用于模拟CHM疾病.
建立一个更准确的模型来研究CHM中RPE退化背后的机制.

主要方法:

利用CRISPR/Cas9基因编辑创建两个同源的hiPSC线条:一个CHM淘汰线和一个纠正的CHM患者线.
分化了hiPSCs成为视网膜色素表皮 (hiPSC-RPE) 细胞.
对关键的RPE标志物,形态和功能,包括视网膜器官的形成,进行了分化hiPSC-RPE细胞的特征.

主要成果:

生成的hiPSC-RPE线路表现出重要的原生RPE特征,包括紧密的结点标记物 (Claudin-19,Zonula Occludens-1),色素和细胞活性.
这些细胞保持了转移后的状态和特有的多边形形状.
所有研究的细胞系都成功形成了视网膜器官,表明它们对复杂的视网膜结构建模的潜力.

结论:

建立了新的同位素hiPSC线和差异化hiPSC-RPE细胞,作为胆红病的有价值的新细胞模型.
这个模型准确地总结了关键的RPE特征和与疾病相关的特征.
为未来研究CHM中RPE退化的病原和潜在治疗方法的开发提供了一个强大的工具.

关键词:

这就是CRISPR/Cas9的作用.胆固醇血症是什么胆固醇血症人类诱导的多能干细胞干细胞.视网膜色素表皮质是视网膜色素表皮质.

更多相关视频

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Published on: April 12, 2021

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...